Industrial Technology Research Institute

I-Horng Pan

Chu-Hsun Lu

Shu-Fang Wen

Yi-Cheng Cheng

Kuo-Kuei Huang

Wei-Lun Fan

Chien-Chun Yang

I-Huang Lu

Hsin-Jan Yao

Ming-Tsuen Hsieh

Wen-Huang Peng

Zong-Keng Kuo

Suey-Sheng Kao

Pei-Hsin Lin

Pei-Yi Tsai

Hsin-Chieh Wu

Meng-Nan Lin

Mei-Hueih Chen

Jennline Sheu

Ming-Han Li

Hsi-Ho Chiu

Pei-Ru Liau

Yeong-Sheng Tsai

Chaur-Ting Ju

Zhi-Jie Huang

Yu-Ming Hsieh

Jir-Mehng Lo

Tien-Soung Tong

Shu-Jiau Chiou

Ying-Fei Tsai

Chi-Chien Lin

Hsiang-Wen Tseng

Mei-Wei Lin

Der-Yuan Chen

Ching Te Lu

Shyh-Horng Lin

Ching-Huai Ko

Kai-An Chuang

Chaurp-Ting Ju

Hsi-Ho Chiou

Po-Yao Hsu

Joung-Liang Lan

Chun-Chung Wang

Chih-Hsuan Chang

A method of treating or alleviating autoimmune-related diseases is provided. The method includes administering a pharmaceutical composition to a subject in need thereof. Moreover, the pharmaceutical composition includes an extract of-as an effective ingredient and a pharmaceutically acceptable carrier or salt.

Method for treating or alleviating autoimmune-related diseases

A method of treating or alleviating autoimmune-related diseases is provided. The method comprises administering a pharmaceutical composition to a subject in need thereof. Moreover, the pharmaceutical composition comprises an extract of Amomum tsao-ko as an effective ingredient and a pharmaceutically acceptable carrier or salt.

The present disclosure provides a method for preparing an extract ofwith an effect of treating skin diseases, including: (a) performing an extraction procedure onwith an extraction solvent to obtain an extract solution; and (b) adding at least one glycoside hydrolases to the extract solution to make an enzyme reaction occur to produce a precipitate, wherein the precipitate is the extract ofwith an effect of treating skin diseases.

Method for preparing an extract ofwith an effect of treating skin diseases, extract ofwith an effect of treating skin diseases and pharmaceutical composition containing the extract

The present disclosure provides a pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis, including: an effective amount of an extract of a plant belonging toas an effective ingredient for treating or alleviating the autoimmune disease and/or complication thereof and/or nephritis, wherein the autoimmune disease is selected from a group consisting of lupus erythematosus, psoriasis, psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis, Crohn's disease and ulcerative colitis (UC).

Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis

The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of an extract ofor an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of an extract ofor an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.

Pharmaceutical compositions and method for inhibiting angiogenesis

The disclosure provides a method for modulating Th17 cells, including: administering an(also namedor) extract to a subject in need thereof, wherein theextract has an effect of modulating Th17 cells. Theextract may include a fruiting body extract ofor a mycelium extract of

Method for modulating Th17 cells and method for treating a disease related to modulation of Th17 cells

A pharmaceutical mixture for the treatment of hepatitis and its preparation method are disclosed. The method includes the following steps: pulverize the plants, macerate and extract the plant with water, concentrate the aqueous extract as the first concentrate; add ethanol to form a precipitate, collect and concentrate the liquid phase to form the second concentrate, and dry it; pass the second concentrate through the resin, elute with water, water-ethanol mixture and ethanol, collect and concentrate the water-ethanol and ethanol elution fraction as the third concentrate, and dry it. The plants in the present invention areThunberg,or the nettle family.

Pharmaceutical mixture for hepatitis treatment and its preparation method

[object Object]

The present invention relates to a composition for liver protection and a preparing method of the same, the processes are as follows: grinding Artemisiae Capillaris and Gardeniae Fructus, mixing with pure water, and boiling the mixture. Then, adding the Rhei Rhizoma alcohol solution into the mixture for extraction to form the first solid phase and the first liquid phase, further concentrating the first liquid phase to form a concentrate, and adding alcohol into the concentrate for precipitation to form the second solid phase and second liquid phase, and separating the second solid phase and drying.

Composition for treating diseased liver

This invention relates to a novel method for preparing pesticide microcapsules in which the release rate and the release period of the pesticide are controlled. A process has been discovered for encapsulating a trace amount of pesticide with a urea-formaldehyde resin, mechanically stirring the resin in the presence of vegetable oil and the pesticide and reacting the mixture under suitable conditions to form a desired pesticide microcapsule.

Preparation of pesticide microcapsule

A biocidal formulation with improved resistance to ultraviolet rays comprising: (a) an appropriate biocide which is Bacillus thuringiensis; (b) an anti-ultraviolet agent selected from the group consisting of 2-(2-H-benzotriazole-2-yl)-phenol and their derivatives represented by the following formula: ##STR1## wherein R.sub.1 and R.sub.2 are independently selected from the group consisting of alkyl, aryl, and alkylaryl groups; (c) pre-gelatinized starch; and (d) natural starch, the biocide, the anti-ultraviolet agent, the pre-gelatinized starch and the natural starch are mixed then baked at 60.degree.-90.degree. C. to form the biocidal formulation.

Anti-ultraviolet biocidal composition

Biocidal formulations prepared by: (a) blending predetermined amounts of pre-gelatinized starch, natural starch, biocide such as Bacillus thuringiensis and water to form a mass; (b) drying said mass by heating prepared by with a hot roller at temperatures between 50.degree. and 100.degree. C., preferably between 60.degree. and 90.degree. C., to form a dried mass; and (c) crushing the dried mass to form the final product having the shape of flakes with a diameter preferably less than about 900.mu.. With the method disclosed in the present invention, the process time can be reduced from 24 hours in the prior art to no more than 30 minutes, preferably about 3 to 15 minutes. The present invention represents substantial economic benefits as well as reductions of potential health risks as a result of the reduced contact by operators with biocides during the preparation process.

Method for the preparation of a biocidal formulation containing starch

Growing community of inventors

Hsinchu, Taiwan

I-Horng Pan